DPHARMA
Quarterly rpt on consolidated results for the financial period ended 30/9/2003
DUOPHARMA BIOTECH BHD |
Quarterly report for the financial period ended | 30/09/2003 |
Quarter | 3 |
Financial Year End | 31/12/2003 |
The figures | have not been audited |
SUMMARY OF KEY FINANCIAL INFORMATION30/09/2003 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
30/09/2003 | 30/09/2002 | 30/09/2003 | 30/09/2002 | ||
RM'000 | RM'000 | RM'000 | RM'000 | ||
1 | Revenue | 18,057 | 15,828 | 57,839 | 27,660 |
2 | Profit/(loss) before tax | 5,839 | 4,871 | 17,931 | 8,035 |
3 | Profit/(loss) after tax and minority interest | 4,325 | 3,522 | 13,242 | 5,910 |
4 | Net profit/(loss) for the period | 4,325 | 3,522 | 13,242 | 5,910 |
5 | Basic earnings/(loss) per share (sen) | 8.65 | 7.13 | 26.48 | 24.37 |
6 | Dividend per share (sen) | 0.00 | 0.00 | 5.00 | 0.00 |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
7 | Net tangible assets per share (RM) | 1.6600 | 1.5000 |
Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my
Remarks : |
The results of the Group for the preceding year corresponding period ended 30 September 2002 is consolidated from the date of acquisition of Duopharma (M) Sendirian Berhad ("DMSB"). Accordingly, the Group's income statement for the preceding year corresponding period ended 30 September 2002 would only reflect the 5 months apportionment results of DMSB. The proforma nine (9) months results of the Group for period ended 30 September 2002 is reflected in note B1 to the interim financial statements. |
Announcement Info
Company Name | DUOPHARMA BIOTECH BHD |
Stock Name | DBIOTEC |
Date Announced | 20 Nov 2003 |
Category | Financial Results |
Reference No | CS-031118-32535 |